Related Experiment Video
Updated: Nov 26, 2025

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Distinct Hepatitis B and HIV co-infected populations in Canada
Curtis Cooper1, Matt Driedger1, David Wong2
1University of Ottawa, Ottawa, Ontario, Canada.
Insights
HIV-HBV co-infection is common. Canadian HIV-HBV patients are older, more male, have advanced fibrosis, and higher treatment use than HBV-only patients. Risk behaviors and origin define distinct HIV-HBV subgroups.
Area of Science:
- Hepatology
- Infectious Diseases
- Clinical Epidemiology
Background:
- Human immunodeficiency virus (HIV) and Hepatitis B virus (HBV) co-infection presents unique clinical challenges due to shared transmission routes.
- Understanding the characteristics of co-infected individuals is crucial for refining clinical management strategies.
- The Canadian Hepatitis B Network Cohort provides a valuable dataset for evaluating HIV-HBV co-infection.
Purpose of the Study:
- To compare the demographic, biochemical, fibrotic, and treatment profiles of patients with HIV-HBV co-infection versus HBV mono-infection.
- To identify factors associated with advanced fibrosis in the co-infected population.
- To delineate distinct subpopulations within the HIV-HBV co-infected group.
Main Methods:
- A cross-sectional analysis of the Canadian Hepatitis B Network Cohort.
- Inclusion of 5996 HBV-infected patients, with 335 identified as HIV-HBV co-infected.
- Comparison of demographic, clinical, and treatment data between HIV-HBV and HBV-only groups, and subgroup analysis based on risk exposure and country of origin.
Main Results:
- HIV-HBV patients were older, had a higher male proportion, lower Asian representation, more advanced fibrosis, and greater anti-HBV therapy use (91% vs. 30%) compared to HBV-only patients.
- High-risk exposure activities were more prevalent in HIV-HBV patients.
- HIV-HBV patients reporting high-risk behaviors differed from those born in endemic countries regarding ethnicity and cirrhosis prevalence. Age ≥60, male sex, elevated ALT, comorbidities, and HCV co-infection predicted fibrosis, but HIV status did not independently predict advanced fibrosis.
Conclusions:
- Canadian patients with HIV-HBV co-infection exhibit distinct characteristics compared to those with HBV mono-infection.
- HIV-HBV patients reporting high-risk behaviors and those originating from endemic countries represent two clinically relevant, distinct subpopulations.
- These findings necessitate tailored approaches for managing HIV-HBV co-infected individuals based on their specific risk factors and origins.
Abstract:
Due to shared modes of exposure, HIV-HBV co-infection is common worldwide. Increased knowledge of the demographic and clinical characteristics of the co-infected population will allow us to optimize our approach to management of both infections in clinical practice. The Canadian Hepatitis B Network Cohort was utilized to conduct a cross-sectional evaluation of the demographic, biochemical, fibrotic and treatment characteristics of HIV-HBV patients and a comparator HBV group. From a total of 5996 HBV-infected patients, 335 HIV-HBV patients were identified. HIV-HBV patients were characterized by older median age, higher male and lower Asian proportion, more advanced fibrosis and higher anti-HBV therapy use (91% vs. 30%) than the HBV-positive / HIV seronegative comparator group. A history of reported high-risk exposure activities (drug use, high-risk sexual contact) was more common in HIV-HBV patients. HIV-HBV patients with reported high-risk exposure activities had higher male proportion, more Caucasian ethnicity and higher prevalence of cirrhosis than HIV-HBV patients born in an endemic country. In the main cohort, age ≥60 years, male sex, elevated ALT, the presence of comorbidity and HCV seropositivity were independent predictors of significant fibrosis. HIV seropositivity was not an independent predictor of advanced fibrosis (adj OR 0.75 [95%CI: 0.34-1.67]). In conclusion, Canadian co-infected patients differed considerably from those with mono-infection. Furthermore, HIV-HBV-infected patients who report high-risk behaviours and those born in endemic countries represent two distinct subpopulations, which should be considered when engaging these patients in care.
More Related Videos
08:11Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
11:00Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...